Skip to main content
SpringerLink
Log in

Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection

  • Articles
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Combinations of ciprofloxacin with azlocillin, piperacillin and ticarcillin were tested in vitro against clinical isolates. Azlocillin plus ciprofloxacin showed synergy against 30% of Pseudomonas aeruginosa isolates; it was either synergistic or additive against 78% of all isolates tested even those resistant to the beta-lactam. Synergism was rarely noted for Klebsiella pneumoniae, Escherichia coli, Enterobacter spp. or Branhamella spp. isolates. Minimum inhibitory concentrations of ciprofloxacin plus azlocillin, plus piperacillin and plus ticarcillin against Pseudomonas spp. were reduced 4 or 2 fold, respectively. However, the combination azlocillin plus ciprofloxacin showed primarily indifference against gram-positive strains. Neutropenic mice infected with a lethal challenge of Pseudomonas spp. were protected by a combination of azlocillin and ciprofloxacin. Its additive and/or synergistic effects and expanded spectrum of activity against streptococci, methicillin-resistant staphylococci and JK corynebacteria may provide an alternative to traditional therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bodey, G., Boliver, R., Fainstein, V., Jadeja, L.: Infections caused byPseudomonas aeruginosa. Review of Infectious Diseases 1983, 5: 279–313.

    Google Scholar 

  2. Young, L. S.: The clinical challenge of infections due toPseudomonas aeruginosa. Reviews of Infectious Diseases 1984, 3, Supplement: 603–607.

    Google Scholar 

  3. Neu, H. C.: The role ofPseudomonas aeruginosa in infections. Reviews of Infectious Diseases 1983, 1, Supplement B: 1–13.

    Google Scholar 

  4. Phair, J. P., Watanakunakorn, C., Bannister, T.: In vitro susceptibility ofPseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Applied Microbiology 1969, 18: 303–306.

    PubMed  Google Scholar 

  5. Comber, K. B., Basker, M. J., Osborne, C. D., Sutherland, R.: Synergy between ticarcillin and tobramycin againstPseudomonas aeruginosa andEnterobacteriaceae in vitro in vivo. Antimicrobial Agents and Chemotherapy 1977, 11: 956–964.

    PubMed  Google Scholar 

  6. Neu, H. C., Fu, K. P.: Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins. Antimicrobial Agents and Chemotherapy 1978, 13: 813–819.

    PubMed  Google Scholar 

  7. Fu, K. P., Neu, H. C.: Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrobial Agents and Chemotherapy 1978, 13: 356–367.

    Google Scholar 

  8. Fass, R. J.: Comparative in vitro activities of betalactam-tobramycin combinations againstPseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli. Antimicrobial Agents and Chemotherapy 1982, 21: 1003–1006.

    PubMed  Google Scholar 

  9. Daschner, F., Langmaack, H., Grelyn, M., Steffens, A., Just, M.: Combination of piperacillin with four aminoglycosides on non-fermenting gram-negative bacteria. Chemotherapy 1981, 27: 39–43.

    PubMed  Google Scholar 

  10. Zinner, S. H., Klastersky, J., Gaya, H., Bernard, C., Ryff, J. C.: In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria andStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1981, 20: 463–469.

    PubMed  Google Scholar 

  11. Andriole, V. T.: Synergy of carbenicillin and gentamicin in experimental infection withPseudomonas. Journal of Infectious Diseases 1971, 124, Supplement: 46–55.

    Google Scholar 

  12. Scott, R. E., Robson, H. R.: Synergistic activity of carbenicillin and gentamicin in experimentalPseudomonas bacteremia in neutropenic rats. Antimicrobial Agents and Chemotherapy 1976, 10: 646–651.

    PubMed  Google Scholar 

  13. Andriole, V. T.: Antibiotic synergy in experimental infection withPseudomonas. II. The effect of carbenicillin, cephalothin or cephanol combined with tobramycin and gentamicin. Journal of Infectious Diseases 1974, 129: 124–133.

    PubMed  Google Scholar 

  14. Norden, C. W., Shaffer, M. A.: Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused byPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1982, 21: 63–65.

    Google Scholar 

  15. Anderson, E. T., Young, L. S., Hewitt, W. L.: Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy 1978, 24: 45–54.

    PubMed  Google Scholar 

  16. Klastersky, J.: Empiric treatment of infections in neutropenic patients with cancer. Reviews of Infectious Diseases 1983, 5, Supplement: 21–31.

    Google Scholar 

  17. Neu, H. C.: Changing mechanism of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection. American Journal of Medicine 1984, 76, Supplement 5A: 11–27.

    Google Scholar 

  18. Appel, G. B., Neu, H. C.: The nephrotoxicity of antimicrobial agents. New England Journal of Medicine 1977, 296: 722–728.

    PubMed  Google Scholar 

  19. Kuck, N. A., Testa, R. T., Forbes, M.: In vitro and in vivo antibacterial effects of combinations of betalactam antibiotics. Antimicrobial Agents and Chemotherapy 1981, 19: 634–638.

    PubMed  Google Scholar 

  20. Neu, H. C., Labthavikul, P.: Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime, and moxalactam. Journal of Antimicrobial Chemotherapy 1982, 9, Supplement A: 101–106.

    PubMed  Google Scholar 

  21. Wu, D. H., Baltch, A. L., Smith, R. P., Conley, P. G.: Effect of aztreonam in combination with azlocillin or piperacillin onPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1984, 26: 519–521.

    PubMed  Google Scholar 

  22. Sanders, C. C., Sanders, W. E.: Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Reviews of Infectious Diseases 1983, 5: 639–648.

    PubMed  Google Scholar 

  23. Neu, H. C., Chin, N. X.: A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its. clinical significance. Chemioterapia 1985, 4: 63–70.

    PubMed  Google Scholar 

  24. Neu, H. C.: Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin. Journal of Antimicrobial Chemotherapy 1982, 10, Supplement C: 63–68.

    PubMed  Google Scholar 

  25. Neu, H. C.: The new beta-lactamase stable cephalosporins. Annals of Internal Medicine 1982, 97: 408–419.

    PubMed  Google Scholar 

  26. Chin, N. X., Neu, H. C.: Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984, 28: 319–326.

    Google Scholar 

  27. Eliopolous, G. M., Gardella, A., Moellering, R. C., Jr.: In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent. Antimicrobial Agents and Chemotherapy 1984, 25: 331–335.

    PubMed  Google Scholar 

  28. Reeves, D. S., Bywater, M. J., Holt, H. A., White, L.: In vitro studies with ciprofloxacin, a new 4-quinolone compound. Journal of Antimicrobial Chemotherapy 1984, Supplement B: 338–346.

    Google Scholar 

  29. Schiff, J. B., Small, G. J., Pennington, J. E.: Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimentalPseudomonas aeruginosa pneumonia. Antimicrobial Agents and Chemotherapy 1984, 26: 1–4.

    PubMed  Google Scholar 

  30. Norden, C., Skinner, E.: Ciprofloxacin as therapy for experimental osteomyelitis. Journal of Infectious Diseases 1985, 151: 291–294.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases-Epidemiology, Departments of Medicine and Pharmacology, College of Physicians and Surgeons, Columbia University, 630 West 168 Street, 10032, New York, New York, USA

    N. X. Chin, K. Jules & H. C. Neu

Authors
  1. N. X. Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Jules
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. C. Neu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chin, N.X., Jules, K. & Neu, H.C. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. Eur. J, Clin. Microbiol. 5, 23–28 (1986). https://doi.org/10.1007/BF02013456

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013456

Keywords

Search

Navigation